A
Artiva Biotherapeutics, Inc.
ARTV · NASDAQ · Healthcare · 560M
Price · close
$10.93
-1.89% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.4×
Enterprise value / EBITDAEV/EBITDA
-3.1×
Free cash flow yieldFCF yield
-29.7%
Return on equityROE
-76.3%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.